There was a single case of NMO relapse reported as a SAE during months 7–12 of the extension in one of four AQP4 antibody-positive patients who experienced relapses during the entire study; this case has been discussed previously [7]. This evidence concerns the gene AQP4 and neuromyelitis optica.